Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
hemangioma_treatment [2020/06/04 21:51] – [Dosing] Scott Larsonhemangioma_treatment [2025/04/18 20:40] (current) – external edit 127.0.0.1
Line 48: Line 48:
     * if PHACE is suspected: MRI/ MRA of head and neck and Echocardiogram      * if PHACE is suspected: MRI/ MRA of head and neck and Echocardiogram 
     * Slow titration up, lowest effective dosing, inpatient observation and TID dosing      * Slow titration up, lowest effective dosing, inpatient observation and TID dosing 
-=== Outpatient Treatment Initiation Protocol === +=== Protocol === 
-  - Baseline BP and HR +[[propranolol_for_hemangioma_protocol|See Outpatient Treatment of hemangioma with Propranolol Protocol]]
-  - Propranolol 0.5 mg/kg (1 mg/kg/day) PO BID +
-  - Check BP and HR 1 and 2 hours after first dose +
-  - IF not tolerated:  gradually increase to 0.5 mg/kg PO +
-  - IF tolerated: Ensure minimum of 6 hours between doses, warning signs, feed regularly and hold dose if PO intake compromised,  Discharge to home +
-  - In 3-7 days: Increase dose to 0.75 mg/kg PO BID (1.5 mg/kg/day)  +
-  - Check BP and HR 1 and 2 hours after new dose  +
-  - If not tolerated:  Keep at 1 mg/kg/day and assess efficacy +
-  - If tolerated: discharge home +
-  - In 3-7 days Increase dose to 1 mg/kg PO BID (2 mg/kg/day)  +
-  - Check BP and HR at 1 and 2 hours after new dose+
  
 === Treatment Location === === Treatment Location ===
Line 83: Line 73:
  
 =====Other Treatments===== =====Other Treatments=====
 +  * Surgical Excision
  
- 
-  * Surgical Excision 
 ===== References ===== ===== References =====
 +  * See [[propranolol_for_hemangioma_protocol|Protocol for Outpatient Propranolol for Infantile and Childhood Hemangioma]] 
   * A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma 2015 {{:oral_propranolol_in_infantile_hemangioma_randomized_controlled_trial_nejm.pdf|PDF}}   * A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma 2015 {{:oral_propranolol_in_infantile_hemangioma_randomized_controlled_trial_nejm.pdf|PDF}}
   * Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference 2013{{http://pediatrics.aappublications.org/content/131/1/128?sso=1&sso_redirect_count=1&nfstatus=401&nftoken=00000000-0000-0000-0000-000000000000&nfstatusdescription=ERROR%3a+No+local+token|Journal of Pediatrics}}   * Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference 2013{{http://pediatrics.aappublications.org/content/131/1/128?sso=1&sso_redirect_count=1&nfstatus=401&nftoken=00000000-0000-0000-0000-000000000000&nfstatusdescription=ERROR%3a+No+local+token|Journal of Pediatrics}}